Quantum eMotion Corp. (TSXV: QNC) (OTCQB: QNCCF), a leader in classical and quantum cybersecurity, is making significant strides in the field of digital healthcare with the development of a groundbreaking remote patient monitoring and digital therapeutics platform. In a recent clinical study conducted in collaboration with Greybox Solutions Inc., Centre hospitalier de l’Université de Montréal (CHUM), Boehringer Ingelheim (Canada) Ltd., and MEDTEQ+, the platform showcased remarkable success in treating heart failure outpatients.
The study demonstrated a significant reduction in emergency room visits and/or hospitalizations, as well as a 23% decrease in healthcare costs. These preliminary results were presented at the American Heart Association’s Scientific Sessions, indicating the potential of this technology to revolutionize heart failure treatment. With over 750,000 Canadians living with heart failure and escalating healthcare costs projected to reach $2.8 billion annually by 2030, this groundbreaking platform has the potential to make a significant impact.
The remote patient monitoring platform, known as Takecare, incorporates a self-care application for patients, a clinical dashboard for remote monitoring by healthcare professionals, a digital therapeutics module that provides automated medication suggestions to the treatment team, and educational modules for patients. This comprehensive approach addresses the key challenges in heart failure treatment and aims to improve patient outcomes while reducing the burden on healthcare systems.
Quantum eMotion CEO, Francis Bellido, expressed his excitement about the study’s success and its implications for the company’s cybersecurity platform, Sentry-Q. He emphasized the critical role of robust cybersecurity in safeguarding sensitive patient data, particularly in the era of escalating data breaches. Bellido also commended the strong partnership of Greybox Solutions with Boehringer Ingelheim, highlighting the pharmaceutical company’s visionary approach to digital therapeutics.
As the demand for digital healthcare continues to rise, driven by the COVID-19 pandemic and estimated to reach a value of $191.9 billion by 2026, Quantum eMotion is committed to providing state-of-the-art cybersecurity to ensure the utmost protection in this rapidly evolving landscape. Their mission to address the growing demand for affordable hardware security for connected devices aligns perfectly with the needs of the digital healthcare market.
FAQs
What is Quantum eMotion’s remote patient monitoring platform?
Quantum eMotion has developed a remote patient monitoring platform called Takecare. It incorporates a self-care application for patients, a clinical dashboard for remote monitoring by healthcare professionals, a digital therapeutics module that provides automated medication suggestions, and educational modules for patients.
What were the results of the recent clinical study?
The recent clinical study showcased remarkable success in treating heart failure outpatients using Quantum eMotion’s remote patient monitoring platform. It demonstrated a significant reduction in emergency room visits and/or hospitalizations, as well as a 23% decrease in healthcare costs.
How does Quantum eMotion ensure the security of patient data?
Quantum eMotion understands the critical importance of cybersecurity in safeguarding sensitive patient data. Their Sentry-Q cybersecurity platform provides enhanced security for protecting high-value assets and critical systems, ensuring the utmost protection of patient data.
What is the potential impact of Quantum eMotion’s remote patient monitoring platform?
With over 750,000 Canadians living with heart failure and escalating healthcare costs, Quantum eMotion’s remote patient monitoring platform has the potential to revolutionize heart failure treatment. By improving patient outcomes and reducing healthcare burdens, it can make a significant impact on the healthcare system.